Intralesional cyclosporine versus dithranol in the treatment of plaque- type psoriasis

European Journal of Dermatology

Volumn 7, Issue 7, 1997, Pages 492-496

  Petronić Rosić, Vesna M ^a   Marinković, Jelena M ^a   Cvijetić, Olivera B ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cyclosporine; Dithranol; Intralesional; Local treatment; Psoriasis

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; DITHRANOL;

ARTICLE; CLINICAL ARTICLE; DRUG CLEARANCE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADERMAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; MALE; PAIN; PSORIASIS; SCORING SYSTEM; SKIN IRRITATION; SKIN PIGMENTATION; SKINFOLD THICKNESS;

EID: 0030813581     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. A consensus report: cyclosporin A therapy for psoriasis. Br J Dermatol 1990; 122 (suppl. 36): 1-3.
2. Christophers E, Mrowietz U, Henneicke H-H, Färber L, Welzel D. Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. J Am Acad Dermatol 1992; 26: 86-90.
3. Messana JM, Rocher LL, Ellis CN, Fradin MS, van Gurp JR, Cantu-Gonzales G, Parish TG, Wheeler SM, Voorhees JJ. Effects of cyclosporine on renal function in psoriasis patients. J Am Acad Dermatol 1990; 23: 1288-93.
4. Fradin MS, Ellis CN, Voorhees JJ. Management of patients and side effects during cyclosporine therapy for cutaneous disorders. J Am Acad Dermatol 1990; 23: 1265-75.
5. Bennett WM. Renal effects of cyclosporine. J Am Acad Dermatol 1990; 23: 1280-7.
6. Takashima A, Morita A, Tsuji T. Treatment of PUVA- and retinoid-PUVA-resistant severe psoriasis with systemic cyclosporin A. J Dermatol 1990; 17: 482-8.
7. Higgins E, Munro C, Marks J, Friedmann PS, Shuster S. Relapse rates in moderately severe chronic psoriasis treated with cyclosporin A. Br J Dermatol 1989; 121: 71-4.
8. Van Joost TH, Heule F, Stolz F, Beukers R. Short-term use of cyclosporin A in severe psoriasis. Br J Dermatol 1986; 114: 615-20.
9. Griffiths CEM, Powles AV, Leonard JM, Fry L. Clearance of psoriasis with low dose cyclosporin. Br Med J 1986; 293: 731-2.
10. Timonen P, Friend D, Abeywickrama K, Laburte C, Von Graffenried B, Feutren G. Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies. Br J Dermatol 1990; 122 (suppl. 36): 33-9.
11. Griffiths CEM. Systemic and local administration of cyclosporin in the treatment of psoriasis. J Am Acad Dermatol 1990; 23: 1242-7.
12. Gilhar A, Winterstein G, Golan DT. Topical cyclosporin in psoriasis. J Am Acad Dermatol 1988; 18: 378-9.
13. Schultz HJ, Mahrle G, Steigleder GK. Topical cyclosporin in psoriasis. Br J Dermatol 1990; 122 (suppl. 36): 113-23.
14. Powles AV, Baker BS, McFadden J, Rutman AJ, Griffiths CEM, Fry L. Intralesional injection of cyclosporine in the treatment of psoriasis. (Letter) Lancet 1988; 1: 537.
15. Powles AV, Baker BS, McFadden JP, Valdimarsson H, Fry L. Intralesional cyclosporine in psoriasis. Acta derm venereol (Stockh) 1989; suppl 146: 148-50.
16. Ho VC, Griffiths CEM, Ellis CN, Gupta AK, McCuaig CC, Nickoloff BJ, Cooper KD, Hamilton TA, Voorhees JJ. Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic and pharmacokinetic study. J Am Acad Dermatol 1990; 22: 94-100.
17. Baker BS, Powles AV, Savage CR, McFadden JP, Valdimarsson H, Fry L. Intralesional cyclosporin in psoriasis: effects on T lymphocyte and dendritic cell sub-populations. Br J Dermatol 1989; 120: 207-13.
18. Burns MK, Ellis CN, Eisen D, Duell E, Griffiths CEM, Annesley TM, Hamilton TA, Birnbaum JE, Voorhees JJ. Intralesional cyclosporine for psoriasis: relationship of dose, tissue levels and efficacy. Arch Dermatol 1992; 128: 786-90.
19. van de Kerkhof PCM. Dithranol treatment for psoriasis: after 75 years, still going strong! A review. Eur J Dermatol 1991; 1: 79-88.
20. Statham BN, Ryatt KS, Rowell NR. Short-contact dithranol therapy-a comparison with the Ingram regime. Br J Dermatol 1984; 110: 703-8.
21. Levell NJ, Munro CS, Higgins EM, Marks JM, Friedmann PS, Shuster S. The absence of rapid relapse of psoriasis treated with cyclosporin A: a comparison with dithranol. Br J Dermatol 1992; 127 (suppl. 4): 18.
22. van Diest PJ, Baak JPA, Matze-Cok P, Wisse-Brekelmans ECM, van Galen CM, Kurver PHJ, Bellot SM, Fijnheer J, van Gorp LHM, Kwee WS, Los J, Peterse JL, Ruitenberg HM, Schapers RFM, Schipper MEL, Somsen JG, Willig WPM, Ariens ATh. Reproducibility of mitosis counting in 2,469 breast cancer specimens. Results from the multicenter morphometric mammary carcinoma project. Hum Pathol 1992; 23: 603-7.
23. Berth-Jones J. Current management of psoriasis: cyclosporin. J Dermatol Treat 1997; 8: 27-55.
24. Chang EY, Hammemberg C, Fisher G, Baadsgaard O, Ellis CN, Voorhees JJ. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis. Arch Dermatol 1992; 128: 1479-85.
25. Gottlieb SL, Heftler NS, Gilleaudeau P, Johnson R, Vallat VP, Wolfe J, Gottlieb AB, Krueger JG. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study. J Am Acad Dermatol 1995; 33: 637-45.
26. Delfino M, Brunetti B, Fabbrocini G. Topical cyclosporine is ineffective in the treatment of psoriasis. Int J Dermatol 1992; 31: 895.
27. Mizoguchi M, Kawaguchi K, Ohsuga Y, Ikari Y, Yanagawa A, Mizushima Y. Cyclosporin ointment for psoriasis and atopic dermatitis. Lancet 1992; 339: 1120.